SONOVEIN
Varicose Veins (Truncal Vein Incompetence)
CommercialActive - CE Mark, FDA Pivotal Complete
Key Facts
Indication
Varicose Veins (Truncal Vein Incompetence)
Phase
Commercial
Status
Active - CE Mark, FDA Pivotal Complete
Company
About Theraclion
Theraclion's mission is to disrupt invasive surgery through its proprietary robotic HIFU (echotherapy) platform, enabling precise, non-invasive tissue ablation. The company has achieved commercial traction with its SONOVEIN system for varicose veins, supported by CE Mark and FDA-pivotal trial data, and is expanding its geographic footprint. Its strategy focuses on dominating the non-invasive venous treatment segment while leveraging its adaptable platform for future indications in oncology and beyond.
View full company profile